4 L-Glutamate is the major excitatory neurotransmitter in the mammalian central nervous system, and plays important roles in many neuronal processes such as fast synaptic transmission and neuronal plasticity (1, 2) . To use L-glutamate as an intercellular signaling molecule, neuronal cells develop glutamatergic systems comprising the storage of glutamate in synaptic vesicles and its exocytosis (signal output), glutamate receptors (signal input), and glutamate reuptake systems (signal termination). Recent evidence has indicated that peripheral endocrine cells also develop glutamatergic systems (3, 4) . For instance, mammalian pinealocytes, endocrine cells for melatonin, secrete L-glutamate through Ca 2+ -dependent regulated exocytosis and use it as a paracrine-or autocrine-like chemical transmitter to inhibit melatonin synthesis (3, 4) . Vesicular glutamate transporter plays its primary role in the storage of L-glutamate in neurons (5, 6 ) and endocrine cells (3, 4) through the transport of L-glutamate at the expense of an electrochemical gradient of protons that is established by vacuolar H + -ATPase. Although vesicular glutamate transporter has been characterized to some extent, its protein nature has not been known long. Very recently, brain-specific Na + -dependent inorganic phosphate cotransporter (BNPI), representing a family of proteins that use the inwardly directed Na + gradient across the membrane and transport inorganic phosphate (7) , has been identified as the vesicular glutamate transporter in synaptic vesicles (8, 9) . Upon expression in either PC12 or BON6 cells, BNPI becomes associated with secretory vesicles and accumulates L-glutamate (8, 9) . BNPI is associated with synaptic vesicles in various glutamatergic neurons (8) (9) (10) (11) .
However, it is not present in all glutamatergic neurons (8) (9) (10) (11) , suggesting that another vesicular glutamate transporter(s) may function in the neurons lacking BNPI (12) .
Differentiation-associated Na + -dependent inorganic phosphate cotransporter (DNPI), a homologue of BNPI isolated from AR42J cells differentiating into neuroendocrine cells, shows 82 % amino acid identity and 92 % similarity to human BNPI (13) . In human and rat, the DNPI gene as well as the DNPI protein was shown to be expressed in neurons in various regions, especially in the encephalon, its expression patterns being somewhat different from that of BNPI (14) (15) (16) . Furthermore, DNPI was shown to be located in synaptic vesicles in the neocortex (16) . One can expect that DNPI is another vesicular glutamate transporter. In the present study, we tested this hypothesis, and found that DNPI shows ATPdependent glutamate transport activity when expressed in COS7 cells. We also showed that besides in neurons DNPI is also present in pinealocytes, αTC6 cells, and α and pancreatic polypeptide-secreting F cells in Langerhans islets, which contain a glutamatergic system.
EXPERIMENTAL PROCEDURES

Organs and Cell cultures
Pineal glands and Langethans islets were isolated from male Wistar rats at postnatal weeks 6. COS7 cells and αTC6 cells, a clonal α cell line (17), were maintained in Dulbecco's modified Eagle medium (DMEM, GIBCO) supplemented with 10 % fetal calf serum, 55 µg/ml sodium pyruvate, 4.5 g/l glucose, 0.1 mg/l streptomycin, 100 units/ml penicillin G and 0.25 mg/l fungizone, and incubated at 37 o C under 5 % CO2. The dispersed cells were washed three times with the above medium, and then placed in a 35 mm culture dish coated with poly-L-lysine to give 2.0 x 10 5 cells/dish, and cultured in the above medium at 37 o C under 5 % CO2. Pinealocytes were cultured as described previously (18) . For experimental procedures, cells were maintained for 5 days, washed with culture medium, cultured further for 1 h, and then used for experiments.
Expression of DNPI
Rat DNPI cDNA, as previously described (13) , was subcloned into the EcoRI site of expression vector pcDNA3.1 (Invitrogen, San Diego, CA, USA). The resultant construct, DNPI-pcDNA3.1, was used to transfect COS7 cells by lipofection using Trans IT reagent (Mirus, Madison, WI, USA). COS7 cells were grown in DMEM containing 10 % fetal calf serum, penicillin, and streptomycin in a humidified incubator at 37 ˚C with 5 % CO2. After incubation for 24 h in 35 mm dishes, DNPI-pcDNA3.1 or the pcDNA3.1 vector alone was For Northern blot analysis, mRNA (4.5 µg) isolated from pineal gland or other tissues was separated on a formaldehyde agarose gel (1 %) and then transferred to a nylon membrane (Amersham). The immobilized RNA was probed with cDNA fragments of DNPI labeled with [ 32 P]dCTP by random priming. After extensive washing, the membrane was subjected to autoradiography using BAS 1000 film (Fuji Film Co.).
L-Glutamate or D-aspartate uptake
DNPI-expressing COS7 cells were rinsed with 1 ml of buffer comprising 20 mM MOPS-Tris (pH 7.0), 0.3 M sucrose, 2 mM Mg-acetate and 4 mM KCl. The cells were then permeabilized for 10 min at 37 o C in 0.5 ml of the same buffer containing 10 µM digitonin (19, 20) . The medium was then replaced with fresh buffer containing Tris-ATP at 2 mM in the absence of digitonin. In some experiments, bafilomycin A1 or other chemicals were also included in the medium at the specified concentrations. Then, glutamate uptake was immediately started by the addition of radioactive L-glutamate (2.5 µCi, 0.1 mM) at 37 o C as described previously (20) . After 10 min incubation, uptake was terminated by washing the cells twice with 1 ml of ice-cold 20 mM MOPS-Tris (pH 7.0) containing 0.3 M sucrose. Then, 7 the cells were lysed with 1 ml of 1 % SDS, and the radioactivity and protein concentration were measured. In some experiments, radiolactive D-aspartate (2.5 µCi, 0.1 mM) was used for the substrate.
Antibodies
Site-specific polyclonal antibodies against rat DNPI were raised in rabbits using synthetic polypeptides corresponding to the C-terminal 12 residues, C-DAYSYKDRDDYS 
Immunohistochemistry
The published procedure was used (21, 22) . In brief, cells on poly L-lysine-coated glass coverslips were fixed in 4 % paraformaldehyde for 20 min, washed with phosphatebuffered saline, incubated with the same buffer containing 0.1 % Triton X-100 for 30 min, then further with 2 % goat serum and 0.5 % bovine serum albumin in the same buffer, and finally reacted with antibodies at the specified dilution as described in the figure legends in phosphate-buffered saline containing 0.5 % bovine serum albumin for 1 h at room temperature. The samples were washed three times with phosphate-buffered saline and then reacted with the second antibodies for 1 h at room temperature. The second antibodies used were AlexaFluor 568-labeled anti-mouse IgG at 1 µg/ml, AlexaFluor 488-labeled anti rabbit IgG at 2 µg/ml, Cy3-labeled goat anti-rat IgG at 1 µg/ml, Cy3-labeled anti-rabbit IgG at 2 µg/ml or FITC-labeled anti-guinea pig IgG at 2 µg/ml. These second antibodies were obtained from Amersham or Molecular Probes. Finally, immunoreactivity was examined under an Olympus Fluoview FV300 confocal laser microscope. 
Other procedures and chemicals
RESULTS
DNPI as a Vesicular Glutamate Transporter
To examine whether or not DNPI is vesicular glutamate transporter, DNPI was expressed in COS7 cells. As shown in Fig. 1A , anti-DNPI antibodies recognized a major broad protein band corresponding to an apparent molecular mass of ~65 kDa when DNPI-9 pcDNA3.1, a DNPI expressing vector, was transfected to COS7 cells. The molecular mass corresponding to the DNPI immunoreactivity is similar to that expected from its primary amino acid sequence and DNPI from the brain (Fig. 1A) . Two additional protein bands with an apparent molecular mass of ~72 and ~42 kDa were also observed. Neither untransfected control COS7 cells nor COS cells transfected with a control vector expressed any DNPI gene, as revealed on RT-PCR analysis (data not shown), or the immunoreactive polypeptide (Fig. 1A) .
The DNPI immunoreactivity disappeared when the antigenic polypeptide was included during antibody treatment (Fig. 1A) . These results indicated that DNPI is expressed in COS7 cells.
The expressed DNPI distributed throughout COS7 cells (Fig. 1B) .
Immunohistochemical analysis indicated that DNPI is co-localized with EEA1 or rab 5, early endosomal markers (Fig. 1C) . DNPI is partially co-localized with GM130, a marker protein of the cis Golgi appratus, but not with PDI, a marker protein of endoplasmic reticulum (Fig. 1C) .
These results suggest that DNPI is mainly associated with early endosomes in the cells.
We examined whether or not DNPI shows vesicular glutamate transport activity. As shown in Fig. 1D (25) (26) (27) . Inability that DNPI transports D-aspartate was also confirmed by the direct uptake assay (Fig. 1D ).
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Together, these results indicate that DNPI is responsible for the vesicular storage of Lglutamate.
DNPI is co-localized with SLMVs in pinealocytes
Besides the central nervous system, peripheral endocrine tissues possess glutamatergic systems (3, 4) . Mammalian pinealocytes accumulate L-glutamate in SLMVs, counterparts of synaptic vesicles in endocrine cells, and secreted it to the extracellular space through exocytosis (28, 29) . Vesicular glutamate transporter is responsible for the storage of L-glutamate in pineal SLMVs (27, 30) . To determine whether or not DNPI is expressed in pinealocytes, expression of the DNPI gene in pineal gland was examined by RT-PCR using specific DNA probes. As shown in Fig. 2A , amplified products of expected size for DNPI were obtained when total RNAs isolated from pineal glands and cultured pineal cells as well as brain were used. The nucleotide and deduced amino acid sequences of the amplified products exactly matched that of the DNPI gene. Northern blot analysis with the amplified RT-PCR products further demonstrated the expression of mRNA for DNPI in pineal glands: two major bands (~3.2 and 4.1 kb) for pineal glands and brain mRNA were detected (Fig. 2B) .
Western blot analysis indicated that the anti-DNPI antibodies recognized a single polypeptide of ~ 65 kDa in pineal glands, cultured pinealocytes and brain membranes (Fig. 2C) . The DNPI immunoreactivity was blocked when the nitrocellulose sheet was treated with an antigenic peptide during the immunodecoration (Fig 2C) . Overall, it is concluded that DNPI is expressed in pineal glands and cultured pinealocytes.
Immunohistochemistry with frozen-sectioned pineal gland revealed the localization of DNPI at the cellular level. We used the following cell markers to classify DNPI-positive cells: synaptophysin for pinealocytes (30, 31) , GFAP for astrocytes (32), OX-42 for microglia (33) , and vimentin for interstitial cells (34) . The antibodies against these marker proteins immunostained the corresponding populations of pineal cells with a similar morphology, as reported previously (33) (Fig. 2D) . The DNPI-positive cells coincided with synaptophysin, but not with any of the above mentioned cell markers, indicating that pinealocytes contain DNPI (Fig. 2D) . Essentially the same results were obtained for cultured pineal cells (data not shown). DNPI and synaptophysin are enriched in the process terminal regions, the site 11 for glutamate exocytosis (3,4) (Fig. 2E) . These results strongly suggested that DNPI is associated with SLMVs in pinealocytes.
DNPI in cells of Langerhans islets
Langerhans islets express various types of ionotropic glutamate receptors and reuptake systems (36) (37) (38) . Clonal pancreatic αTC6 cells store and secrete L-glutamate through exocytosis, the mechanism being similar to those in neurons and pinealocytes (20) . Thus, it is possible that Langerhans islets are another example of an endocrine glutamatergic system and that DNPI is responsible for the storage of L-glutamate in the islets. To examine this possibility, the expression of DNPI in αTC6 cells and islets was measured. RT-PCR analysis indicated the presence of DNPI mRNA in αTC6 cells (Fig. 3A) . Western blotting and immunohistochemistry indicated the presence of DNPI in αTC6 cells (Fig. 3B,C) . (Fig. 3B) . DNPI was co-localized with glucagon but not with insulin or somatostatin in horizontal sections of the islets, indicating the presence of DNPI in α cells but not in β or δ cells (Fig. 3C) . DNPI is also co-localized with pancreatic polypeptides. These results suggested that DNPI is mainly present in α cells and partially in pancreatic polypeptide-secreting F cells (Fig. 3C) .
DISCUSSION
Vesicular glutamate transporter is responsible for the glutamatergic characteristics of neurons and was originally identified in synapsin I-associated synaptic vesicles (25, 39) . In the earlier stage of studies, vesicular glutamate transporter was defined as the ATP-dependent proton conductor-sensitive glutamate transport activity in synaptic vesicles, but little was known about the protein nature of the transporter at the molecular level (25) (26) (27) 39) . In the last year, two groups have independently reported that BNPI is vesicular glutamate transporter itself, and that BNPI is a potential tool for substantial studies on vesicular 12 glutamate transporter. DNPI is a potential candidate for another vesicular glutamate transporter, since DNPI is distributed throughout the brain, being especially abundant in the nerve endings of glutamatergic neurons, where BNPI is scarce (15, 16 The fact that DNPI exhibits vesicular glutamate transport activity is not surprising, since the amino acid identity of the core portions of DNPI and BNPI excluding their hydrophilic N-and C-terminal regions are over 90 % with 12 putative transmembrane helices (7, 13) . In the original studies on the expression and functions of BNPI and DNPI, both proteins were found to facilitate the transport of inorganic phosphate depending on extracellular Na + (7, 13) . On the other hand, vesicular glutamate transporters use a proton as a coupling ion, and only recognize L-glutamate and a few cyclic glutamate analogues as substrates (25) (26) (27) 39) . Thus, DNPI and BNPI are versatile in their coupling ions and substrate specificity in nature. Further studies will be necessary to elucidate the molecular mechanism underlying the versatility, and to assign the domains responsible for the Na + -dependent inorganic phosphate transport and proton-coupled glutamate transport.
Significant finding in this study is that DNPI is expressed in glutamatergic endocrine function to store L-glutamate in SLMVs and secrete it through exocytosis, which is one of the components of the negative regulatory mechanism for melatonin synthesis. Not all pinealocytes processes are positive for DNPI (Fig. 2E, arrows and arrowheads) , indicating the functional heterogeneity of SLMVs in pinealocytes, as suggested by Redecker (42) .
It should be emphasized that DNPI is present in αTC6 cells and α cells in Langerhans islets. DNPI is also present in pancreatic polypeptide-secreting F cells, suggesting that pancreatic polypeptide-secreting F cells are capable of storing and secreting L-glutamate. Therefore, α cells and possibly pancreatic peptide-secreting F cells are the sites for the glutamate release in the islets, which was first proposed by Weaver et al., (38) .
Thus, Langerhans islets may equip their own input, output and termination systems for glutamate signals. Although the physiological role(s) of the glutamatergic system in the islets is not fully understood at present, the glutamate may regulate the secretion of insulin and glucagon by way of its binding to the receptors in α and β cells (43, 44) . A role of Lglutamate as an intracellular signaling molecule in β cells, which enhances the second phase of insulin secretion, has also been postulated (45) .
In conclusion, DNPI is an indicator for glutamatergic systems in peripheral tissues as well as neurons, and is a very useful probe for studies on peripheral glutamatergic systems.
We are extensively studying the localization of DNPI in various organs, which will reveal the site where L-glutamate acts as an intercellular signaling molecule in peripheral organs. (100 µg protein) were solubilized with SDS sample buffer and then subjected to SDS polyacrylamide gel electrophoresis followed by immunoblotting using anti-DNPI antibodies. 
